...
首页> 外文期刊>Clinical chemistry and laboratory medicine: CCLM >Determination of asymmetric dimethyl arginine in human serum by liquid chromatography-tandem mass spectrometry: clinical application in hypertensive subjects
【24h】

Determination of asymmetric dimethyl arginine in human serum by liquid chromatography-tandem mass spectrometry: clinical application in hypertensive subjects

机译:液相色谱-串联质谱法测定人血清中的不对称二甲基精氨酸:在高血压患者中的临床应用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Asymmetric dimethylarginine (ADMA), an endogenous competitive inhibitor of nitric oxide synthase plays an important role in endothelial dysfunction processes. Recent studies have linked high ADMA levels with several pathological conditions. The interest as a marker of endothelial dysfunction has increased in the last few years. In this paper, a method for serum ADMA quantification by liquid chromatography tandem mass spectrometry has been described. To test the utility in a pathological condition ADMA levels in hypertensive subjects have been measured. Methods: HPLC separation was performed by hydrophilic interaction chromatography using acetonitrile/water containing 0.1% formic acid and 20 mmol/L ammonium formate. Selected reaction monitoring was performed following the transitions m/z 203.1--46.4 for ADMA and 210.1--46.3 for the internal standard [~2H_7]ADMA..
机译:背景:不对称二甲基精氨酸(ADMA)是一氧化氮合酶的内源性竞争抑制剂,在内皮功能障碍过程中起着重要作用。最近的研究已经将高ADMA水平与几种病理状况联系在一起。在最近几年中,作为内皮功能障碍标志物的兴趣有所增加。本文介绍了一种通过液相色谱串联质谱法定量血清ADMA的方法。为了在病理条件下测试效用,已经测量了高血压受试者中的ADMA水平。方法:采用亲水相互作用色谱法,使用乙腈/水(含0.1%甲酸和20 mmol / L甲酸铵)进行HPLC分离。遵循ADMA的m / z 203.1--46.4和内标[〜2H_7] ADMA的210.1--46.3转换,进行了选定的反应监控。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号